What is Nuvation Bio Inc (NUVB) stock price today?

Nuvation Bio Inc (NUVB) currently trades at $4.34 per share. The stock has a market capitalization of $1.51B and a P/E ratio of —x.

Is NUVB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Nuvation Bio Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is —.

What is Nuvation Bio Inc's revenue and earnings?

Nuvation Bio Inc has trailing twelve-month (TTM) revenue of $62.90M with profit margins of 0.00%. Earnings per share (EPS) is $-0.60.

Is Nuvation Bio Inc financially healthy?

Nuvation Bio Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of — places it in the —.

NUVB

Nuvation Bio Inc

NYSE: NUVB · HEALTHCARE · BIOTECHNOLOGY

$4.34

-4.82% today

Updated 2026-04-29

Market cap

$1.51B

P/E ratio

—

P/S ratio

23.99x

EPS (TTM)

$-0.60

Dividend yield

—

52W range

$2 – $10

Volume

4.2M

Market cap

$1.51B

P/E ratio

—

P/S ratio

23.99x

EPS (TTM)

$-0.60

Dividend yield

—

52W range

$2 – $10

Volume

4.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.3

Growth

7.8

Quality

B+

2.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$12.33

+184.10%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 633.00% QoQ

+ Debt/equity 0.18x — low leverage

Risks

- Thin margins at 0.00%

- Negative free cash flow $-29.82M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$7.87M	$62.90M	$62.90M
Net income	$-104.20M	$-75.80M	$-567.94M	$-204.63M	$-36.59M
EPS	—	—	—	—	$-0.60
Free cash flow	$-96.48M	$-68.07M	$-130.57M	$-173.78M	$-29.82M
Profit margin	—	—	-7,213.76%	-325.31%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NUVB	$1.51B	31	6.3	2.5	5.0	7.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Nuvation Bio Inc trades at $4.34. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $62.90M.

Frequently asked questions

What is Nuvation Bio Inc's stock price?

Nuvation Bio Inc (NUVB) trades at $4.34.

Is Nuvation Bio Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Nuvation Bio Inc (NUVB)?

The analyst target price is $12.33, representing +184.1% upside from the current price of $4.34.

What is Nuvation Bio Inc's revenue?

TTM revenue is $62.90M.

Piotroski F-Score?

4/9 — moderate financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE

CurrencyUSD

www.nuvationbio.com

Quick metrics

P/S ratio23.99x

ROE-53.20%

Beta1.61

50D MA$4.77

200D MA$4.93

Shares out0.35B

Float0.24B

Short ratio—

Avg volume4.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NUVB vs LLY →NUVB vs JNJ →NUVB vs ABBV →Stock screener →